LILLY

LILLY

Displaying 10 out of 8 results

  1. FILE PHOTO: Loxo Oncology CEO Joshua Bilenker and Chief Business Officer Jacob Van Naarden stand fo

    Eli Lilly to put Loxo executives in charge of new cancer research unit

    U.S. drugmaker Eli Lilly and Co said on Thursday it will create a new cancer research division that will be run by top executives from Loxo ...
  2. The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co

    Lilly's pancreatic cancer treatment fails late-stage study

    Eli Lilly and Co said on Wednesday its experimental pancreatic cancer treatment in combination with a cocktail of chemotherapies did not meet the ...
  3. Logo of Bayer AG is pictured ahead of the the annual results news conference of the German drugmake

    Inside drugmakers' strategy to boost cancer medicines with 'Lazarus effect'

    In the halls of MD Anderson Cancer Center, the drug Vitrakvi is known for having a "Lazarus effect" in some patients because it can reverse ...
  4. The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the NYSE in New

    Eli Lilly tops profit estimates on boost from diabetes drugs

    Eli Lilly and Co edged past Wall Street estimates for quarterly revenue on Tuesday, as higher sales of its top-selling diabetes drug, Trulicity, ...
  5. FILE PHOTO: Lilly logo on a wall of Lilly France, part of Eli Lilly and Co, in Fegersheim, France

    FDA approves Lilly's migraine drug as first ever cluster headache treatment

    Eli Lilly and Co's migraine treatment Emgality on Tuesday became the first drug to gain U.S. approval for decreasing the frequency of episodic ...
  6. FILE PHOTO: Lilly logo on a wall of Lilly France, part of Eli Lilly and Co, in Fegersheim, France

    Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

    Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new patients to a new ...
  7. The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the NYSE in New

    Eli Lilly misses estimates for diabetes drug Trulicity, cuts revenue forecast

    Eli Lilly and Co's first-quarter profit more than tripled, as the U.S. drugmaker recorded a US$3.7 billion gain from its spin-off of animal health ...